Patents by Inventor Katherine D. Collier

Katherine D. Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF REMOVING OILY STAINS FROM FABRICS
    Publication number: 20110312064
    Abstract: Described are compositions and methods for removing oily stains from fabrics by treating the fabrics with cyclodextrins. Cyclodextrins can be added to the fabrics or generated in situ by converting a substrate of starch or dextrin with cyclomaltodextrin glucanotransferase.
    Type: Application
    Filed: November 30, 2009
    Publication date: December 22, 2011
    Applicant: DANISCO US INC.
    Inventors: Christian D. Adams, Katherine D. Collier, Thjs Kaper, Brian F. Schmidt
  • Enzymes With Lipase Activity
    Publication number: 20110281324
    Abstract: Described are detergent compositions comprising at least one lipase enzyme selected from SriII, ScoIIA, ScoIIB, CefII, and variants, thereof. The compositions are useful for removing oily stains from fabric.
    Type: Application
    Filed: November 30, 2009
    Publication date: November 17, 2011
    Applicant: Danisco US Inc.
    Inventors: Christian D. Adams, Kai Bao, Katherine D. Collier, Edwin Lee, Andrei Miasnikov, Zhen Qian, Brian F. Schmidt, Danfeng Song
  • Phosphate Limited Inducible Promoter and A Bacillus Expression System
    Publication number: 20110262953
    Abstract: An evolvable production strain of B. subtilis exhibiting continuous or high level expression during protein evolution is described. An evolved Bacillus subtilis pstS promoter facilitates screening and production of secreted proteins.
    Type: Application
    Filed: November 19, 2010
    Publication date: October 27, 2011
    Applicant: Danisco US Inc.
    Inventors: Katherine D. Collier, Edwin Lee, Nicholas Leiva, Thomas B. Morrison, Volker Schellenberger, Olga V. Selifonova, Adam C. Kean
  • Modified Variant Bowman Birk Protease Inhibitors
    Publication number: 20110256608
    Abstract: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
    Type: Application
    Filed: April 8, 2011
    Publication date: October 20, 2011
    Applicant: Danisco US Inc.
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • Modified variant Bowman Birk protease inhibitors
    Patent number: 7947475
    Abstract: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: May 24, 2011
    Assignee: Danisco US Inc.
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • Phosphate limited inducible promoter and a expression system
    Patent number: 7858762
    Abstract: An evolvable production strain of B. subtilis exhibiting continuous or high level expression during protein evolution is described. An evolved Bacillus subtilis pstS promoter facilitates screening and production of secreted proteins.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: December 28, 2010
    Assignee: Genencor International, Inc.
    Inventors: Katherine D Collier, Edwin Lee, Nicholas Leiva, Thomas B Morrison, Volker Schellenberger, Olga V Selifonova, Adam C Kean
  • Modified variant bowman birk protease inhibitors
    Patent number: 7803902
    Abstract: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: September 28, 2010
    Assignee: Danisco US Inc.
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • Modified Variant Bowman Birk Protease Inhibitors
    Publication number: 20100221780
    Abstract: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
    Type: Application
    Filed: May 13, 2010
    Publication date: September 2, 2010
    Applicant: DANISCO US INC.
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
    Patent number: 7772181
    Abstract: The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses the compositions comprising the modified variant BBPIs, and the methods for making and using the compositions in personal care.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: August 10, 2010
    Assignee: Danisco US Inc.
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS
    Publication number: 20100092409
    Abstract: The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses the compositions comprising the modified variant BBPIs, and the methods for making and using the compositions in personal care.
    Type: Application
    Filed: October 15, 2008
    Publication date: April 15, 2010
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS
    Publication number: 20100093028
    Abstract: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
    Type: Application
    Filed: October 15, 2008
    Publication date: April 15, 2010
    Inventors: Neelam S. Amin, Katherine D. Collier, Melodie Estabrook, David A. Estell, Bryan P. Fox, Scott D. Power, Brian F. Schmidt, Gudrun Vogtentanz
  • Repeat sequence protein polymer active agent congjugates, methods and uses
    Patent number: 7691806
    Abstract: Biomolecular conjugates are provided which comprise the conjugation product of a repeat sequence protein polymer and at least one active agent. Additional aspects provide methods for their manufacture and various industrial and consumer applications.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: April 6, 2010
    Assignee: Genencor International, Inc.
    Inventors: Katherine D. Collier, William A. Cuevas, Manoj Kumar
  • Multiply-substituted protease variants with altered net charge for use in detergents
    Publication number: 20080274938
    Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Protease variants are provided that contain substitutions of the amino acids at one or more residue positions so that the substitution alters the charge at that position to make the charge more negative or less positive compared to a precursor protease and thus the protease variant is more effective in a low detergent concentration system than a precursor protease.
    Type: Application
    Filed: October 27, 2006
    Publication date: November 6, 2008
    Inventors: Ayrookaran J. Poulose, Volker Schellenberger, James T. Kellis, Paech Christian, Joanne Nadherny, Donald P. Naki, Katherine D. Collier, Robert M. Caldwell
  • Multiply-substituted protease variants with altered net charge for use in detergents
    Patent number: 7129076
    Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Protease variants are provided that contain substitutions of the amino acids at one or more residue positions so that the substitution alters the charge at that position to make the charge more negative or less positive compared to a precursor protease and thus the protease variant is more effective in a low detergent concentration system than a precursor protease.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: October 31, 2006
    Assignee: Genencor International, Inc.
    Inventors: Ayrookaran J. Poulose, Volker Schellenberger, James T. Kellis, Jr., Christian Paech, Joanne Nadherny, Donald P. Naki, Katherine D. Collier, Robert M. Caldwell
  • Method of assaying wash performance of enzymes on a microtiter plate
    Patent number: 7122334
    Abstract: A microtiter method for assaying the wash performance of new enzymes and/or new detergent formulations is described.
    Type: Grant
    Filed: July 26, 2004
    Date of Patent: October 17, 2006
    Assignee: Genencor International, Inc.
    Inventors: Volker Schellenberger, Donald P. Naki, Katherine D. Collier, James T. Kellis, Jr., Joanne Nadherny
  • Enzyme feed additive and animal feed including it
    Patent number: 7005128
    Abstract: The use is provided of a composition as a feed additive which comprises one or more endoglucanases, and 0–20% by weight, based upon the content of cellulase proteins in the composition, of a cellobiohydrolase. The endoglycanases may be one or more of EGI, EGII, EGIII and any functionally active derivative of any thereof. Such endoglucanases may be obtained from a genetically modified strain of the fungus Trichoderma. Also provided is an enzyme-based feed additive which comprises EGI and/or EGII which lack the cellulose binding domain, and 0–20% by weight, based upon the content of cellulase proteins in the additive, of a cellobiohydrolase. A further enzyme-based feed additive is provided which comprises a cereal-based carrier, one or more endoglucanases, and 0–20% by weight, based upon the content of cellulase proteins in the additive, of a cellobiohydrolase. Such enzyme-based feed additives can be incorporated into a cereal-based feed which includes one or more of barley, wheat, triticale, rye and maize.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: February 28, 2006
    Assignees: Genencor International, Inc., Finnfeeds International, Ltd.
    Inventors: Michael R. Bedford, Andrew J. Morgan, Timothy Fowler, Kathleen A. Clarkson, Michael Ward, Katherine D. Collier, Edmund A Larenas
  • Multiply-substituted protease variants
    Patent number: 6927055
    Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: August 9, 2005
    Assignee: Genencor International, Inc.
    Inventors: Ayrookaran J. Poulose, Volker Schellenberger, James T. Kellis, Jr., Christian Paech, Joanne Nadherny, Donald P. Naki, Katherine D. Collier, Robert M. Caldwell, André C. Baeck
  • Cleaning compositions containing multiply-substituted protease variants
    Patent number: 6838425
    Abstract: The present invention relates to cleaning compositions comprising a protease variant.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: January 4, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Chanchal Kumar Ghosh, André Cesar Baeck, Ryohei Ohtani, Alfred Busch, Michael Stanford Showell, Ayrookaran J. Poulose, Volker Schellenberger, James T. Kellis, Jr., Christian Paech, Joanne Nadherny, Donald P. Naki, Katherine D. Collier, Robert M. Caldwell
  • Method of assaying for a preferred enzyme and/or preferred detergent composition
    Publication number: 20040261193
    Abstract: An improved method for assaying the wash performance of new enzymes and/or new detergent formulations is described
    Type: Application
    Filed: July 26, 2004
    Publication date: December 30, 2004
    Inventors: Volker Schellenberger, Donald P. Naki, Katherine D. Collier, James T. Kellis, Joanne Nadherny
  • Bleaching compositions comprising multiply-substituted protease variants
    Patent number: 6831053
    Abstract: The present invention relates to bleaching compositions comprising a protease variant.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: December 14, 2004
    Assignee: The Procter & Gamble Company
    Inventors: Chanchal Kumar Ghosh, André Cesar Baeck, Ryohei Ohtani, Alfred Busch, Michael Stanford Showell, Ayrookaran J. Poulose, Volker Schellenberger, James T. Kellis, Jr., Christian Paech, Joanne Nadherny, Donald P. Naki, Katherine D. Collier, Robert M. Caldwell